Dr. Bahaa Shqour from the Faculty of Engineering and Information Technology and Dr. Hiba Al-Natsha from the Faculty of Medicine and Health Sciences publish a scientific paper in the field of 3D printing for medical purposes and pharmaceutical technology

In one of the most prominent research journals in the field of biomaterials science and engineering, with an impact factor of 5.8, Dr. Bahaa Shqour from the Faculty of Engineering and Information Technology and Dr. Hiba Al-Natsha from the Faculty of Medicine and Health Sciences publish a scientific paper in the field of 3D printing for medical purposes and pharmaceutical technology.

In an unprecedented step in Palestine, Dr. Bahaa Shqour, Assistant Professor in the Department of Mechanical and Industrial Engineering at the Faculty of Engineering and Information Technology, and Dr. Hiba Al-Natsha, Assistant Professor in the Department of Pharmacy at the Faculty of Medicine and Health Sciences, along with other colleagues, published a joint paper titled "Modified Release 3D-Printed Capsules Containing a Ketoprofen Self-Nanoemulsifying System for Personalized Medical Application" in the journal ACS Biomaterials Science & Engineering, which is one of the leading journals in the field of biomaterials science and engineering, with an impact factor of 5.8.

This research resulted from collaboration with the Pharmaceutical Technology Laboratory at Ghent University, Belgium, a leading lab in industrial pharmaceutical technology in Europe.

As part of its focus on modern technologies, An-Najah National University has invested in the infrastructure of its laboratories, including the latest equipment, such as a 3D printer dedicated to applied research, the first of its kind in Palestine.

The university expresses its pride in this significant scientific achievement and appreciates the valuable contribution of the researchers, which reflects the spirit of innovation and scientific excellence at the university.

The research highlights the use of 3D printing technology to produce capsules containing an active substance with nano-technology, enabling control over the rate and location of active ingredient release in the human body. The aim is to achieve the best therapeutic results while minimizing side effects.

For more information about the research, you can visit the link: https://pubs.acs.org/doi/abs/10.1021/acsbiomaterials.4c00476.